Miyata Manabu

Asaoka Ryo, Miyata Manabu, Oishi Akio, Fujino Yuri, Murata Hiroshi, Aoki Shuichiro et al.

This study found that for RP clinical trials, using both eyes and enrolling patients in earlier disease stages significantly reduces the required sample size to detect treatment effects.

Kishi Yuka, Ikeda Hanako O, Miyata Manabu, Numa Shogo, Kamei Takuro, Tsujikawa Akitaka

This study found outer retinal tubulations in Bietti crystalline dystrophy correlate with visual field loss severity, but not progression or retinal volume, suggesting their role in advanced disease.

Ikeda Hanako O, Hasegawa Tomoko, Abe Hiroyasu, Amino Yoko, Nakagawa Takayuki, Tada Harue et al.

Oral BCAAs for retinitis pigmentosa showed no significant visual field benefit, but a trend toward slower retinal degeneration was observed. BCAAs were safe, warranting further larger studies.

Asaoka Ryo, Miyata Manabu, Oishi Akio, Fujino Yuri, Murata Hiroshi, Azuma Keiko et al.

This study found that in retinitis pigmentosa, visual field test reproducibility decreases significantly with worsening visual acuity (logMAR > 0.5), requiring careful interpretation in these patients.

Asano Shotaro, Oishi Akio, Asaoka Ryo, Fujino Yuri, Murata Hiroshi, Azuma Keiko et al.

Binomial pointwise linear regression reliably and earlier detected central visual field progression in retinitis pigmentosa, offering a valuable tool for monitoring this inherited retinal disease.

Hata Masayuki, Yamashiro Kenji, Ooto Sotaro, Oishi Akio, Tamura Hiroshi, Miyata Manabu et al.

This study found pachychoroid neovasculopathy has lower intraocular VEGF than nAMD, suggesting different angiogenesis mechanisms. Lower VEGF predicted better anti-VEGF response in PNV, guiding treatment expectations.

Nakano Eri, Hata Masayuki, Oishi Akio, Miyamoto Kazuaki, Uji Akihito, Fujimoto Masahiro et al.

This study found optic disc rim redness is significantly lower in compressive optic neuropathy (CON) than glaucoma (GON) or normal eyes, particularly in early stages. This provides a quantitative tool to help differentiate CON from GON.